Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak
Abstract Background Viral haemorrhagic fevers are characterized by irregular outbreaks with high mortality rate. Difficulties arise when implementing therapeutic trials in this context. The outbreak duration is hard to predict and can be short compared to delays of trial launch and number of subject...
Main Authors: | Pauline Manchon, Drifa Belhadi, France Mentré, Cédric Laouénan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-021-01287-w |
Similar Items
-
A review of lassa fever outbreaks in Nigeria from 1969 to 2017: Epidemiologic profile, determinants and public health response
by: T J Okwor, et al.
Published: (2018-01-01) -
Crimean-Congo Haemorrhagic Fever
by: Hürrem BODUR
Published: (2009-03-01) -
Outbreak of Crimean-Congo haemorrhagic fever with atypical clinical presentation in the Karak District of Khyber Pakhtunkhwa, Pakistan
by: Khalid Rehman, et al.
Published: (2018-11-01) -
Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation
by: Gilsdorf Andreas, et al.
Published: (2012-11-01) -
The first mile: community experience of outbreak control during an Ebola outbreak in Luwero District, Uganda
by: Daniel H. de Vries, et al.
Published: (2016-02-01)